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Introduction {#cam41106-sec-0001}
============

Delirium is a common problem in hospital care, especially for patients with cancer as well as elderly and frail patients [1](#cam41106-bib-0001){ref-type="ref"}. It is a syndrome of brain dysfunction characterized by a disturbance in attention, awareness, and cognition, with a rapid onset that is caused by an underlying medical condition [2](#cam41106-bib-0002){ref-type="ref"}, [3](#cam41106-bib-0003){ref-type="ref"}. The occurrence of delirium depends on a combination of vulnerability (predisposing factors) and precipitating factors that trigger the development of delirium [4](#cam41106-bib-0004){ref-type="ref"}. Risk factors include aging, cognitive impairment, and a history of delirium, and screening for delirium in patients at risk may be of help to reduce suffering from delirium [5](#cam41106-bib-0005){ref-type="ref"}, [6](#cam41106-bib-0006){ref-type="ref"}, [7](#cam41106-bib-0007){ref-type="ref"}, [8](#cam41106-bib-0008){ref-type="ref"}, [9](#cam41106-bib-0009){ref-type="ref"}, [10](#cam41106-bib-0010){ref-type="ref"}, [11](#cam41106-bib-0011){ref-type="ref"}.

Data on the incidence and prevalence of delirium in literature range from a 5% prevalence rate upon admission to a geriatric hospital ward [12](#cam41106-bib-0012){ref-type="ref"} up to an incidence rate of 88% in patients dying from cancer [8](#cam41106-bib-0008){ref-type="ref"}. This diversity in incidence and prevalence rates indicates that it is a serious problem for patients with cancer especially when terminally ill.

In recent publications it has been suggested that prophylactic treatment with antipsychotics should be considered to prevent delirium [13](#cam41106-bib-0013){ref-type="ref"}, [14](#cam41106-bib-0014){ref-type="ref"}, [15](#cam41106-bib-0015){ref-type="ref"}, [16](#cam41106-bib-0016){ref-type="ref"}, [17](#cam41106-bib-0017){ref-type="ref"}, but due to the varying incidence rates of delirium and the sometimes severe side‐effects of these medicines (primarily haloperidol) [18](#cam41106-bib-0018){ref-type="ref"} there is reluctance to apply preventive treatment to all patients with cancer admitted to the hospital.

It would be of clinical significance if one could determine which patients are likely to develop delirium at admission in order to select patients who might benefit from prophylactic treatment.

In this study, the primary aim was to evaluate the occurrence of delirium and its risk factors in patients with cancer admitted to the hospital for treatment or palliative care in order to develop a prediction model to identify patients at high risk for delirium.

Methods {#cam41106-sec-0002}
=======

This retrospective study was conducted in all patients with solid malignancies admitted to our medical oncology ward of the VUmc Cancer Center Amsterdam (CCA), VU University Medical Center, between Jan 1st 2011 and June 30th 2012. For each patient the following data were collected from medical charts: baseline characteristics, presence of delirium, and its risk factors throughout the entire admission. The study was conducted in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Because of the retrospective character of this study no additional informed consent could be obtained and a waiver was obtained from the medical ethical committee.

Screening for delirium was performed twice a week during three consecutive nursing shifts according to standard hospital procedures using the Delirium Observation Screening Scale (DOSS) [12](#cam41106-bib-0012){ref-type="ref"}. The DOSS is a validated 13‐item nurse‐rated screening instrument for delirium that is commonly used in Dutch hospitals. Scores range from 0 to 13 points, with ≥ 3 as a cut‐off for delirium. It has sensitivity and specificity rates of 92% and 82%, respectively [19](#cam41106-bib-0019){ref-type="ref"}. Delirium was recorded as present if the diagnosis was noted in the patient chart, or if the patient had a DOSS score ≥ 3 without a rejection of the delirium diagnosis written down in the chart.

The following risk factors were assessed: age \> 70 years, alcohol or drug abuse, hearing, visual and/or cognitive impairment, history of delirium, high doses of opioids (\>90 mg of oral morphine or equivalent), corticosteroids (\>15 mg dexamethasone or equivalent), and/or sedatives (\>2 mg lorazepam or equivalent), infections, postoperative state (until discharge of major surgery), constipation (note of constipation or note of delayed stool production for \>48 hours), urinary retention, tumor burden and location, organ failure, and metabolic disturbances [4](#cam41106-bib-0004){ref-type="ref"}, [5](#cam41106-bib-0005){ref-type="ref"}, [6](#cam41106-bib-0006){ref-type="ref"}, [7](#cam41106-bib-0007){ref-type="ref"}, [8](#cam41106-bib-0008){ref-type="ref"}, [9](#cam41106-bib-0009){ref-type="ref"}, [10](#cam41106-bib-0010){ref-type="ref"}. In detail these risk factors are depicted in table [1](#cam41106-tbl-0001){ref-type="table-wrap"}. To avoid dependence the first admission with or without delirium for each patient was used for comparisons.

###### 

Predisposing and precipitating factors for delirium

  Predisposing factors
  -----------------------
  Age \> 70 years
  Alcohol or drug abuse
  Hearing impairment
  Visual impairment
  History of delirium
  Cognitive impairment

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Precipitating factors                                                                                                                        
  --------------------------------------- ---------------------------------------------------------------------------------------------------- ----------------------------------------
  High doses of psychotropic medication   Opioids                                                                                              \>90 mg morphine per day or equivalent

  Corticosteroids                         \>15 mg dexamethasone per day or equivalent                                                          

  Sedatives                               \>2 mg lorazepam per day or equivalent                                                               

  Withdrawal                              Alcohol                                                                                              

  Sedatives                                                                                                                                    

  Other                                                                                                                                        

  Infection                               Fever                                                                                                \>38.5°C

  Sepsis                                                                                                                                       

  Urinary tract infection                                                                                                                      

  Pulmonary tract infection                                                                                                                    

  Other infections                                                                                                                             

  Postoperative state                                                                                                                          

  Constipation                                                                                                                                 

  Urinary retention                                                                                                                            

  Intracranial neoplasm                   Primary tumor                                                                                        

  Metastasis                                                                                                                                   

  Carcinomatous meningitis                                                                                                                     

  Organ failure                           Pulmonary failure                                                                                    O~2~ sat \< 88% or PO~2~ \< 55 mm Hg

  Renal insufficiency                     Creatinine \> 312 mmol/L (3 x ULN) or creatinine \> 3 × baseline                                     

  Liver failure                           Bilirubin \> 60 mmol/L (3 × ULN) and/or ASAT \> 150 U/L (5 × ULN) and/or ALAT \> 200 U/L (5 × ULN)   

  Cardiac failure                         Requiring (prolonged) hospitalization                                                                

  Metabolic disturbance                   Calcium (corrected for albumin level)                                                                \<1.75 mmol/L \> 3.1 mmol/L

  Sodium                                  \<130 mmol/L\                                                                                        
                                          \>155 mmol/L                                                                                         

  Potassium                               \<3.0 mmol/L\                                                                                        
                                          \>6.0 mmol/L                                                                                         

  Glucose                                 \<2.2 mmol/L\                                                                                        
                                          \>13.9 mmol/L                                                                                        

  Albumin                                 \<20 g/L                                                                                             
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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Development of a delirium prediction algorithm {#cam41106-sec-0003}
----------------------------------------------

Based on the predisposing factors and the grouped variables for the precipitating factors, a prediction algorithm was developed. For the development of this prediction algorithm, the groups were defined irrespective of the prevalence rates of the individual factors to limit the number of factors included (see Table [1](#cam41106-tbl-0001){ref-type="table-wrap"}). Grouped variables were defined positive if any of the factors in this group was present. Eastern Co‐operative Oncology Group (ECOG) performance status (0--2 vs. 3--4), palliative or curative treatment intention, and whether or not an admission was scheduled were also included in the prediction algorithm. For prediction models, it is recommended that the number of events should ideally be 10‐fold higher than the number of variables included in the model [20](#cam41106-bib-0020){ref-type="ref"}. Therefore, we enriched the database with 46 extra delirium cases that were consecutively diagnosed with DOSS screening between July 2012 and September 2013 (Table [2](#cam41106-tbl-0002){ref-type="table-wrap"}). These baseline characteristics of these cases did not significantly differ from the patients with delirium in the original dataset. The enriched database is suitable for the calculation of odds ratios and the identification of predictors, but not for the calculation of absolute risks [21](#cam41106-bib-0021){ref-type="ref"}. The absolute risks were calculated from the original database.

###### 

Patients included in prediction algorithm

                                                                Delirium *n *=   No delirium *n =*   Total *n =*
  ------------------------------------------------------------- ---------------- ------------------- -------------
  Study period                                                  52               522                 574
  Extra delirium cases[a](#cam41106-note-0002){ref-type="fn"}   46               ---                 46
  Total                                                         98               522                 620

For adequate power in the development of the delirium prediction algorithm, data on the predisposing and precipitating factors of 46 patients who developed delirium between July 2012 and September 2013 were added to the original dataset. These data were only used for the development of this algorithm. Absolute risks at delirium reported in the article were calculated with the original dataset.
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Statistical analysis {#cam41106-sec-0004}
--------------------

Statistical evaluation of differences between nondelirious and delirious patients was performed with a *χ* ^2^‐test, the Fisher exact test, or the Student\'s *t*‐test, whenever appropriate. Because of the multiple comparisons an adjusted *P *= 0.01 was considered statistically significant. To create a delirium risk prediction algorithm that can be easily implemented in the clinic, we used a tree analysis method [22](#cam41106-bib-0022){ref-type="ref"}. All predisposing and the grouped precipitating factors for delirium were used in this tree analysis, irrespective of the *χ* ^2^‐test and students *t*‐test results, to predict the risk of developing delirium in subgroups of patients. The number of splits in the tree was chosen in order to minimize the cross‐validated prediction error. Fivefold cross‐validation was used for validation of the algorithm. For both the original and the cross‐validated model the area under the curve (AUC) was calculated. Data were collected in the web‐based database system OpenClinica version 3.1.2. Statistical tests were performed with SPSS version 20.0. The prediction algorithm was constructed with the software package R program Rpart (version 3.1).

Results {#cam41106-sec-0005}
=======

A total of 574 individual patients were admitted 1733 times during the study period (mean 2.95 admittances per patient, ranging from 1 to 22 admissions per patient). Sixty delirium episodes were recorded for 52 individual patients, which resulted in a delirium incidence rate of 3.5 per 100 admittances. Nine percent of all patients admitted in this period developed delirium.

Patient characteristics {#cam41106-sec-0006}
-----------------------

Of all 1733 admittances, 1003 admittances (57.9%) were scheduled. The mean age of admitted patients was 60 years (SD 13.1) and 60% of the patients were male. Compared with patients who did not develop delirium, patients who developed delirium were significantly older (mean age of 59 vs. 67 years, respectively (*P *\<* *0.001)), had a worse ECOG performance status at admittance, and more often received treatment with palliative intention or palliative care only. Ninety‐four percent of the patients who developed delirium had an unscheduled admittance, compared to 49% of the patients who did not develop delirium (*P *\<* *0.001). In 10 of the 730 unscheduled admittances the indication for the admittance was suspected delirium (*n *=* *2), confusion (*n *=* *5), or drowsiness (*n *=* *3). Seven of these patients were diagnosed with delirium in the hospital. Patients with delirium stayed longer in the hospital, and the outcome was worse. In Table [3](#cam41106-tbl-0003){ref-type="table-wrap"}, these data are shown in detail.

###### 

Patient characteristics

                                                                          Total *n *=* *1733   \%      Total first admittance *n*=574   \%      No delirium *n *=* *522   \%      Delirium *n *=* *52   \%        *P *= [a](#cam41106-note-0003){ref-type="fn"}   OR               95%CI of OR
  ------------------------------------------------ ---------------------- -------------------- ------- -------------------------------- ------- ------------------------- ------- --------------------- --------- ----------------------------------------------- ---------------- --------------
  Age                                              Mean (SD)              57.2 (14.2)                  60.0 (13.1)                              59.3 (13.3)                       68 (8)                          \<0.001                                                          
  Gender                                           M:F                    1076:657             62:38   345:229                          60:40   313:209                   60:40   32:20                 62:39     0.83                                            1.068            0.595--1.919
  Tumor type                                       Gastrointestinal       645                  37      196                              34      179                       34      17                    33                                                                         
  Genitourethral                                   369                    21                   129     22                               119     23                        10      19                                                                                               
  Skin                                             50                     3                    34      6                                25      5                         9       27                                                                                               
  Lung                                             2                      0                    2       0                                2       0                         0       0                                                                                                
  Head & Neck                                      369                    21                   108     19                               100     19                        8       15                                                                                               
  Brain                                            8                      1                    6       1                                4       1                         2       4                                                                                                
  Sarcoma                                          120                    7                    20      4                                20      4                         0       0                                                                                                
  Breast                                           97                     6                    53      9                                48      9                         5       10                                                                                               
  Other                                            73                     4                    26      5                                25      5                         1       2                     0.009                                                                      
  ECOG performance status                          0                      223                  13      96                               17      96                        18      0                     0                                                                          
  1                                                964                    56                   262     46                               252     48                        10      19                                                                                               
  2                                                385                    22                   146     25                               127     24                        19      37                                                                                               
  3                                                132                    8                    56      10                               40      8                         16      31                                                                                               
  4                                                29                     2                    14      2                                7       1                         7       14                    \<0.001                                                                    
  Length of stay                                   Days (Median (IQR))    3 (2--6)                     4 (2--7)                                 4 (2--7)                          10 (5--16)                      \<0.001                                                          
  Outcome                                          Alive                  1692                 98      549                              96      508                       97      41                    79                                                                         
  Deceased                                         41                     2                    25      4                                14      3                         11      21                    \<0.001   9.735                                           4.155--22.809    
  Treatment intention                              Curative               626                  36      174                              30      166                       32      8                     15                                                                         
  Palliative                                       1107                   64                   400     70                               356     68                        44      85                    0.01      2.067                                           1.079--3.958     
  Indication for admittance                        Scheduled admittance   1003                 58      270                              47      267                       51      3                     6                                                                          
  *Chemotherapy*                                   885                    51                   209     36                               208     40                        1       2                                                                                                
  Diagnostic procedures                            68                     4                    40      7                                39      7                         1       2                                                                                                
  Intervention                                     50                     3                    21      4                                20      4                         1       2                                                                                                
  Unscheduled admittance                           730                    42                   304     53                               255     49                        49      94                    \<0.001   17.102                                          5.264--550.560   
  Clinical symptoms                                535                    31                   251     44                               209     40                        42      81                                                                                               
  Complication                                     195                    11                   53      9                                46      9                         7       14                                                                                               
  Delirium Type                                    Hyperactive                                                                                                                    11                    21                                                                         
  Hypoactive                                                                                                                                                              20      39                                                                                               
  Mixed                                                                                                                                                                   18      35                                                                                               
  Unknown[b](#cam41106-note-0004){ref-type="fn"}                                                                                                                          3       6                                                                                                

*P*--values of the comparison between the patients with delirium and the patients without delirium.

Delirium type could not be determined from the information in the patient chart.
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Predisposing and precipitating factors {#cam41106-sec-0007}
--------------------------------------

The most prevalent predisposing factors in this group of patients were age \>70 and alcohol/drug abuse (21% and 8%, respectively). Although all factors were previously defined as predisposing factors, only age \>70 significantly correlated with the development of delirium in univariate analysis (*P *\<* *0.001).

The most prevalent precipitating factors were high doses of psychotropic medication, infection, constipation, and metabolic imbalance (25%, 22%, 19%, and 18%, respectively). The precipitating factors infection, constipation, urinary retention, organ failure, and metabolic imbalance were significantly related with the presence of delirium (*P *\<* *0.001) (Table [4](#cam41106-tbl-0004){ref-type="table-wrap"}).

###### 

Prevalence of predisposing and precipitating factors

                                          Total *n = *574   \%    No delirium *n *=* *522   \%    Delirium *n *=* *52   \%   *P*=                                              Odds Ratio   95% confidence interval OR   
  --------------------------------------- ----------------- ----- ------------------------- ----- --------------------- ---- ------------------------------------------------- ------------ ---------------------------- --
  Predisposing factors                                                                                                                                                                                                   
  Age \> 70                               No                452   79                        421   81                    31   60                                                                                          
  Yes                                     122               21    101                       19    21                    40   \<0.001[a](#cam41106-note-0005){ref-type="fn"}    2.824        1.557--5.119                 
  Alcohol/drug abuse                      No                526   92                        480   92                    46   89                                                                                          
  Yes                                     48                8     42                        8     6                     12   0.43                                              1.491        0.602--3.693                 
  Hearing difficulty                      No                556   97                        508   97                    48   92                                                                                          
  Yes                                     18                3     14                        3     4                     8    0.07                                              3.024        0.958--9.549                 
  Visual impairment                       No                559   97                        511   98                    48   92                                                                                          
  Yes                                     15                3     11                        2     4                     8    0.04                                              3.871        1.187--12.624                
  History of delirium                     No                569   99                        517   99                    52   100                                                                                         
  Yes                                     5                 1     5                         1     0                     0    0.99                                              ---          ---                          
  Cognitive impairment                    No                562   98                        514   99                    48   92                                                                                          
  Yes                                     12                2     8                         2     4                     8    0.02                                              5.354        1.555--18.431                
  Precipitating factors                                                                                                                                                                                                  
  High doses of psychotropic medication   No                428   75                        397   76                    31   60                                                                                          
  *Yes*                                   146               25    125                       24    21                    40   0.01                                              2.151        1.193--3.878                 
  Corticosteroids                         43                7     43                        8     0                     0    0.03                                              ---          ---                          
  Sedatives                               29                5     22                        4     7                     14   0.01                                              3.535        1.432--8.727                 
  Opioids                                 86                15    70                        13    16                    31   0.002[a](#cam41106-note-0005){ref-type="fn"}      2.870        1.513--5.445                 
  Alcohol/drug withdrawal                 No                561   98                        511   98                    50   96                                                                                          
  *Yes*                                   13                2     11                        2     2                     4    0.33                                              1.858        0.401--8.619                 
  Alcohol                                 12                2     11                        2     1                     2    0.99                                              0.911        0.115--7.199                 
  Sedatives                               0                 0     0                         0     0                     0    ---                                               ---          ---                          
  Other                                   2                 0     1                         0     1                     2    0.17                                              10.216       0.630--165.771               
  Infection                               No                448   78                        425   81                    23   44                                                                                          
  *Yes*                                   126               22    97                        19    29                    56   \<0.001[a](#cam41106-note-0005){ref-type="fn"}    5.524        3.062--9.966                 
  Fever                                   48                8     39                        7     9                     17   0.03                                              2.587        1.175--5.694                 
  Sepsis                                  16                3     9                         2     7                     14   \<0.001[a](#cam41106-note-0005){ref-type="fn"}    8.849        3.148--24.879                
  Urinary tract                           30                5     22                        4     8                     15   0.003[a](#cam41106-note-0005){ref-type="fn"}      4.124        1.735--9.803                 
  Respiratory tract                       26                5     17                        3     9                     17   \<.001[a](#cam41106-note-0005){ref-type="fn"}     6.205        2.610--14.750                
  Other                                   30                5     23                        4     7                     14   .01                                               3.368        1.370--8.279                 
  Intracranial neoplasm                   No                538   94                        494   95                    44   85                                                                                          
  *Yes*                                   36                6     28                        5     8                     15   0.01                                              3.208        1.379--7.461                 
  Primary tumor                           8                 1     5                         1     3                     6    0.03                                              6.331        1.469--27.287                
  Metastasis                              24                4     19                        4     5                     10   0.06                                              2.816        1.006--7.885                 
  Carcinomatous meningitis                4                 1     4                         1     0                     0    0.99                                              ---          ---                          
  Post‐operative state                    No                557   97                        509   98                    48   92                                                                                          
  Yes                                     17                3     13                        2     4                     8    0.06                                              3.263        1.024--10.398                
  Constipation                            No                468   82                        433   83                    35   67                                                                                          
  Yes                                     106               19    89                        17    17                    33   0.006[a](#cam41106-note-0005){ref-type="fn"}      2.363        1.268--4.405                 
  Urinary retention                       No                560   98                        514   99                    46   89                                                                                          
  Yes                                     14                2     8                         2     6                     12   0.001[a](#cam41106-note-0005){ref-type="fn"}      8.380        2.788--25.192                
  Organ failure                           No                476   83                        447   86                    29   56                                                                                          
  Yes                                     98                17    75                        14    23                    44   \<0.001[a](#cam41106-note-0005){ref-type="fn"}    4.727        2.596--8.608                 
  Liver failure                           Not measured      77    13                        70    13                    7    13                                                                                          
  No                                      437               76    401                       77    36                    69                                                                                               
  *Yes*                                   60                10    51                        10    9                     17   0.09                                              1.971        0.898--4.326                 
  Bilirubin \>60 mmol/L                   19                4     15                        3     4                     21   0.08                                              2.849        0.903--8.983                 
  ASAT \> 150                             51                10    43                        10    8                     18   0.12                                              2.062        0.902--4.710                 
  ALAT \> 200                             24                5     21                        5     3                     7    0.47                                              1.469        0.421--5.131                 
  Pulmonary insufficiency                 Not measured      380   66                        361   69                    19   37                                                                                          
  No                                      173               30    148                       28    25                    48                                                                                               
  Yes                                     21                4     13                        2     8                     15   0.01                                              7.133        2.806--18.133                
  Renal failure                           Not measured      15    3                         15    3                     0    0                                                                                           
  No                                      543               95    497                       95    46                    88                                                                                               
  Yes                                     16                3     10                        2     6                     12   0.002[a](#cam41106-note-0005){ref-type="fn"}      6.696        2.327--19.239                
  Cardiac failure                         No                565   98                        514   98                    51   98                                                                                          
  Yes                                     9                 2     8                         2     1                     2    0.58                                              1.262        0.155--10.294                
  Metabolic imbalance                     Not measured      20    3                         20    4                     0    0                                                                                           
  No                                      453               79    428                       82    25                    48                                                                                               
  *Yes*                                   101               18    74                        14    27                    52   \<0.001[a](#cam41106-note-0005){ref-type="fn"}    6.538        3.599--11.878                
  Calcium low                             1/411             0     1/362                     0     0/49                  0    0.99                                              ---          ---                          
  Calcium high                            8/411             2     4/362                     1     4/49                  8    0.009[a](#cam41106-note-0005){ref-type="fn"}      7.956        1.923--32.918                
  Potassium low                           30/550            5     21/498                    4     9/52                  9    0.001[a](#cam41106-note-0005){ref-type="fn"}      4.754        2.051--11.022                
  Potassium high                          5/550             1     1/498                     0     4/52                  8    \<0. 001[a](#cam41106-note-0005){ref-type="fn"}   41.417       4.538--378.011               
  Sodium low                              25/544            5     18/493                    4     6/51                  12   0.02                                              3.519        1.330--9.311                 
  Sodium high                             2/544             0     0/493                     0     2/51                  4    0.009[a](#cam41106-note-0005){ref-type="fn"}      ---          ---                          
  Hypoglycemia                            1/395             0     0/350                     0     1/45                  2    0.11                                              ---          ---                          
  Hyperglycemia                           24/395            6     19/350                    5     4/45                  9    0.32                                              1.700        0.551--5.240                 
  Albumin low                             42/442            9     24/393                    6     18/49                 37   \<0.001[a](#cam41106-note-0005){ref-type="fn"}    8.927        4.378--18.206                

*P* \< 0.01.
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Delirium prediction algorithm {#cam41106-sec-0008}
-----------------------------

To determine the most relevant factors for the risk at delirium, a prediction algorithm by using tree analysis was developed using the enriched database. The optimum number of splits, with the lowest cross‐validated prediction error, was four.

The absolute risks in the decision tree, obtained by projecting the algorithm to the original, nonenriched dataset, are depicted in Figure [1](#cam41106-fig-0001){ref-type="fig"}. A patient admitted to the hospital ward has a risk of 9% to develop delirium (95% CI: 6.8--11.7%). The first factor that made a major distinction between a low risk at delirium (1.1% in the original dataset, 95% CI: 0.2--3.2%) and an intermediate risk at delirium (16% in the original dataset, 95% CI: 12--21%) was whether or not an admission was scheduled. Due to the very low risk at delirium (1:100), it was deemed unnecessary to make any further distinctions within the group with a scheduled admittance. In the group with an emergency admission, a further distinction could be made between patients who did or did not have metabolic imbalances. These patients had a delirium risk of 10% and 32.5%, respectively (95% CI: 6--15%, resp. 22--44%). In the group with an unscheduled admittance combined with a metabolic imbalance (delirium risk 1:3), ECOG performance status 0--2 versus ≥3, and curative versus palliative treatment intention were further splits. The AUC of this algorithm was 0.81 (Fig. [2](#cam41106-fig-0002){ref-type="fig"} upper line). We evaluated predictive validity of the algorithm by fivefold cross‐validation. This provided a lower estimate for the AUC of 0.65 (Fig. [2](#cam41106-fig-0002){ref-type="fig"} lower line), as the original algorithm estimates do not correct for uncertainty in the selection of predisposing and/or precipitating factors. The sum of the sensitivity and specificity was maximal at a cut‐off with a high specificity of 85%, and a lower sensitivity of approximately 40% in the cross‐validated algorithm. This cut‐off allows for identification of a subgroup of patients with a high risk at delirium. In the algorithm, the cut‐off is the distinction between patients with an unscheduled admittance with or without metabolic imbalances.

![Delirium prediction algorithm. This risk is defined by the combination of factors mentioned in the boxes, starting with a baseline risk of 9% when a patient is admitted to the medical oncology ward. The \* refers to the square in the corner of the figure in which the metabolic imbalances are defined.](CAM4-6-1861-g001){#cam41106-fig-0001}

![ROC curve of the prediction algorithm for delirium. These curves show the sensitivity and specificity of the different cut‐off points in the algorithm. AUC of the original model (blue line) is 0.81 and 0.65 for the cross‐validated model (green line).](CAM4-6-1861-g002){#cam41106-fig-0002}

We evaluated whether the factors found in this algorithm were also predictive for different admissions of the same patient by comparing the prevalence of unscheduled admittances and metabolic imbalances within patients who had both an admittance with delirium and an admittance without delirium (27/52 patients with delirium). Admittances with delirium were significantly more often unscheduled than admittances without delirium (25/27 vs. 10/27, *P *\<* *0.001). Metabolic imbalances were also more prevalent in the delirium admittance than in the admittance without delirium, but this difference was not statistically significant (12/27 vs. 6/27, *P *=* *0.08). During the admittance with delirium, patients had a higher chance to be in the high‐risk group according to the prediction algorithm (with the combination of an unscheduled admittance and metabolic imbalances), than during the admittance without delirium (12/27 resp. 4/27, *P *=* *0.02).

Discussion {#cam41106-sec-0009}
==========

In this study, medical data from 574 patients during 1733 admittances were evaluated to determine the occurrence of delirium and its risk factors in patients admitted to the hospital for treatment or palliative care. We found a delirium incidence rate of 3.5 per 100 admittances and determined that 9% of all patients admitted in this period developed delirium. The most frequent predisposing factors in this group of patients were age \>70 and alcohol/drug abuse, whereas the most frequent precipitating factors were high doses of psychotropic medication, infection, constipation, and metabolic imbalance.

Because of the large number of patients that were evaluated, it was possible to use both predisposing and precipitating factors to develop an algorithm that may be used in daily practice to identify patients with a high risk to develop a delirium.

The incidence rate of 3.5% per admittance in this evaluation is lower than the 16--18% reported on similar hospital wards [6](#cam41106-bib-0006){ref-type="ref"}, [9](#cam41106-bib-0009){ref-type="ref"}. A reason for the low incidence of delirium on this ward could be that half of the admittances were scheduled for patients to receive chemotherapy or undergo other interventions, as these patients have a low risk at delirium. In the study by Ljubisavljevic and Kelly (2003) these patients were not included, and it is likely that the proportion of scheduled admittances in the study by Gaudreau et al. (2005) was also smaller. When all scheduled admissions are excluded from our dataset, the incidence rate of delirium goes up to 7.8% (57/730), which is still lower than in the aforementioned studies. Another important reason that might explain this low incidence rate could be that the mean age of the patients admitted to this ward was 60 years (only 21% of the patients were aged ≥70 years) and even the elderly patients had a good cognitive performance status, as only 2.1% of all patients had a cognitive impairment.

The selected predisposing and precipitating factors were previously defined for their significant relationship with delirium, but this relationship was not confirmed for all of these factors in this study. This is most likely due to the low prevalence rates of these risk factors. In other studies logistic regression analysis to determine the influence of an individual factor on a patients risk at delirium had been used [8](#cam41106-bib-0008){ref-type="ref"}, [23](#cam41106-bib-0023){ref-type="ref"}. Although the results of these analyses indicate that a patient in whom a certain factor is present has a relatively higher risk at delirium, it does not provide the clinician with a clinical tool to clearly define the absolute risk that a specific patient has to develop delirium. Also, the effect of a combination of multiple predisposing and/or precipitating factors in the same patient is often not clear. Therefore, a prediction algorithm could be of significant clinical value to provide this information. Martinez et al. (2012) developed a prediction rule for patients admitted to the internal medicine ward [24](#cam41106-bib-0024){ref-type="ref"}. This prediction rule could not be applied to our medical oncology ward as the prevalence of some of the components of the prediction rule was too low (e.g., age \> 85 years).

We developed an alternative algorithm in which patients with high risk for delirium are rapidly identified based on an emergency admittance combined with metabolic imbalances (delirium risk 1:3) (see Fig. [1](#cam41106-fig-0001){ref-type="fig"}). These factors are usually available upon admission of a patients with cancer and therefore this algorithm can be easily implemented in daily clinical practice. We here propose that based on this algorithm, patients could be selected for preventive treatment for delirium [12](#cam41106-bib-0012){ref-type="ref"}, [13](#cam41106-bib-0013){ref-type="ref"}, [14](#cam41106-bib-0014){ref-type="ref"}, [15](#cam41106-bib-0015){ref-type="ref"}, [16](#cam41106-bib-0016){ref-type="ref"}.

We do realize that our study has some limitations such as that it is a retrospective evaluation, the number of patients are rather limited to evaluate a high number (\>10) of predisposing factors for delirium, and although it concerns only patients with cancer, tumor diagnosis is heterogeneous. On the other hand, the strength of this study is that no selection has been made for patients with cancer acutely admitted to the hospital and that the algorithm to determine the risk at a delirium can be easily implemented in daily practice.

In future studies, preventive treatment for delirium should be evaluated for its influence on the quality of life of patients, while taking in account the added risk of treatment‐induced toxicity of such a treatment strategy. In addition, as previously advocated by others, we also highly recommend screening of acutely admitted patients for delirium [25](#cam41106-bib-0025){ref-type="ref"}. The specificity for the cut‐off in our algorithm is high (85%), but the sensitivity is only 40%. This means that 60% of the delirium cases would be missed when only attention is being focused at patients in the high‐risk group. Therefore, while preventive treatment of patients identified by our algorithm with a high risk of delirium needs further evaluation, also screening for delirium symptoms in the other patients with an emergency admission should be considered.

In conclusion, delirium is a serious problem for patients with cancer admitted to the hospital. We identified that especially patients undergoing an unscheduled admittance with a metabolic imbalance do have a clinically relevant high risk to develop a delirium. Based on these factors, we propose to evaluate preventive treatment of these patients when admitted to the hospital in order to improve their quality of life.
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